Clinical data under GDPR and MDR
Strict constraints on residency, audit trail, clinical validation, CE marking.
On-premise clinical AI, MDR, sovereign data.
Hospitals, health authorities, research hospitals (IRCCS), private clinics and biomedical research centres that want to use AI on clinical data without letting it leave the perimeter. noze comes from years of projects with Meyer, CNR and European research centres. Public bodies with no clinical activity will find their page under Public Administration.
Strict constraints on residency, audit trail, clinical validation, CE marking.
Reports, discharge letters, imaging, PDFs: data scattered and hard to query.
AI has to support the clinician, cite its sources every time and leave a verifiable trail for every answer.
Continuity of care hard to manage without dedicated tools.
Local clinical chatbot, RAG on FHIR/DICOM, digital twin, SaMD MDR pathway.
GDPR and MDR on clinical data: gap analysis, AI risk classification and audit trail, on-premise.
Vulnerability assessment and pentest of the hospital network and medical devices.
ProductClinical AI governance with Admina Enterprise: AI Act, NIS2 and sovereign health data.
SolutionConsulting on clinical roadmap, validation and CE pathway.
Solution25+ years of applied biomedical research, European projects.
Joint R&D INPECO + BioRobotics Sant'Anna Pisa (EUR 3.5M, 30 researchers): automation and robotics for clinical labs, deep learning on skin lesions.
2008–2010noze system for ISTI-CNR: bioinformatics workflows on an existing computational grid, drag-and-drop Visual Workflow Designer and Web 2.0 CMS.
On 5 August 2026 two OpenAI staff presented their reconstruction of the July incident at Black Hat USA. Token forgery through a legacy refresh endpoint, a Groovy plugin used as a command-execution service, nine CVEs in JFrog Artifactory fixed in versions 7.161.15 and 7.146.34, and a communication channel between separate evaluation runs that appears in no written document from either company.
From 2 August 2026 the AI Act is generally applicable and supervisory authorities have full powers. The checklist of obligations already in force for providers and deployers of AI systems, the ones postponed by the Digital Omnibus and what you need to have ready.
A July 2026 post presents OpenDerm, an $8,500 robotic gantry that scans skin at 78 pixels per millimetre, and argues that the bottleneck in early detection is not the classifier but image acquisition. Three documented cases say the same thing: Thailand in 2019, surgical skin markings in dermoscopy, and the first AI software cleared to guide an ultrasound probe.
Yes. agentichealth is a local clinical chatbot with RAG on FHIR and DICOM: data stays inside the organisation's perimeter, on-premise. datagovern adds GDPR and MDR gap analysis, AI risk classification and an audit trail, all on-premise.
If it qualifies as a medical device, yes, and it has to follow the SaMD pathway under MDR. agentichealth is designed along the SaMD MDR pathway, and the healthcare consulting covers clinical roadmap, validation and the CE pathway.
You need AI that supports the clinician, cites its sources every time and leaves a verifiable trail for every answer. Admina Enterprise brings clinical AI governance across the AI Act, NIS2 and sovereign health data; datagovern keeps the audit trail on-premise.